来源：滚动播报 当地时间2月3日，诺和诺德发布公告称，在2026年3月26日的年度股东大会上，董事会将提议2025年期 末股息为每股7.95丹麦克朗，使2025年预期总股息达到11.70丹麦克朗。董事会决定启动一项新的股票回 购计划，规模最高可达150亿丹麦克朗。 ...

Novo Nordisk (NVO) shares crashed on Tuesday after the Danish drugmaker issued a sobering outlook for 2026 that caught Wall Street flat-footed. According to the pharma giant, its top- and bottom-line growth will decelerate this year as its “Most Favored Nations” agreement with the U.S. lowers weight-loss drug prices in its largest market. More News from Barchart At the time of writing, Novo Nordisk stock is trading some 20% below its year-to-date high. www.barchart.com What This 2026 Outlook Really M ...

Market Overview - Stocks declined on Tuesday, with the S&P 500 falling over 1% and the Nasdaq dropping approximately 2% due to a selloff in technology stocks [1] - Financial stocks, including Blue Owl Capital, KKR, Apollo Global Management, and BlackRock, also experienced declines as the market reacted to potential software losers from AI [1] Company-Specific Updates - Nvidia's stock fell more than 3% on Tuesday, maintaining a flat performance over the past six months; CEO Jensen Huang denied rumors of a fraying relationship with OpenAI during an interview with Jim Cramer [1] - Eli Lilly's shares dropped nearly 4% ahead of its earnings report, influenced by Novo Nordisk's disappointing guidance for 2026, which included a projected sales decline of 5% to 13% year over year [1] - Novo Nordisk's stock fell over 15% after announcing it expects lower sales in the U.S. due to price pressures and increasing competition, suggesting a potential loss of market share to Eli Lilly [1] Housing Market Insights - Housing-related stocks saw a rally following a report indicating efforts to make entry-level home buying more affordable, involving companies like Lennar and Taylor Morrison Home [1] - Despite the broader market decline, Home Depot's shares rose nearly 1%, indicating potential benefits from a revived housing market [1] Upcoming Earnings Reports - Key earnings reports expected after Tuesday's close include Advanced Micro Devices, Super Micro, Chipotle, Enphase Energy, Amgen, Amcor, Prudential Financial, Mondelez, and Corteva [1] - Notable reports before Wednesday's opening bell include GE Healthcare, Uber, Boston Scientific, Johnson Controls, AbbVie, Bunge, and Fortive [1]

本文源自：金融界AI电报 诺和诺德2025财年净利润为1024亿丹麦克朗。 ...

Novo Nordisk A/S (NYSE:NVO) stock is trading lower on Tuesday after the weight-loss drug maker released its 2026 full-year sales and operating profit outlook.2026 OutlookNovo Nordisk expects reported 2026 sales and operating profit to benefit from a $4.2 billion reversal of 340B Drug Pricing Program in the U.S. In 2025, $400 million was excluded.Excluding this one-time item, the mid-point of sales and operating profit growth guidance for 2026, both at CER, would be -1% and 11%, respectively.Adjusted sales g ...

The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook. ...

Novo Nordisk stock (NVO) plunged approximately 15% after the Danish pharmaceutical giant posted better-than-expected 2025 results but delivered a weak 2026 outlook. The company reported full-year 2025... ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss market. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Yes □ No 区 If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g-32(b):82- FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 4 February 2026 NOVO NORDISK A/S (Exact name of Registrant as specified in its charter) Novo Allé DK-2880 Bagsværd Denmark (Address of principal executive offices) Indicate by check mark whether the ...